Drug: VIREAD Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 58162724 | VIREAD | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | F | 3 KG | 20160822 | FR |
| 60548203 | VIREAD | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | F | 0 | 20160822 | DE |
| 69084534 | VIREAD | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | M | 0 | 20160822 | GB |
| 117345112 | VIREAD | Foetal exposure during pregnancy | MERCK | 1.00 DY | F | 2 KG | 20160830 | US |
| 125584302 | VIREAD | Foetal exposure during pregnancy | GILEAD | -0.77 YR | M | 0 | 20160729 | US |
| 127182991 | VIREAD | Foetal exposure during pregnancy | GILEAD | 0.00 | M | 3 KG | 20160906 | IT |
Total Records: 6 Number of Pages: 1